This article in the Jerusalem Post highlights four of the 16 research projects selected for the second cycle of funding by the Israel Precision Medicine Project. 
 

Multidisciplinary projects, including studies on autism, cancers and trauma, get NIS 60 million ($17 million) in grants from Israel Precision Medicine Partnership initiative.

 

In this Jerusalem Press Club webinar, Prof. Yuval Dor, Head of the Life Sciences and Medicine Division at the Israel Science Foundation, presents the 16 winning research proposals selected by the Israel Precision Medicine Partnership (IPMP). 



 

The Israel Precision Medicine Partnership (IPMP) has announced the 14 winning research proposals that will comprise its inaugural cohort. NIS 60 million will be awarded during the current grant cycle to enable the expansion of personalized precision medicine in Israel and to facilitate medical breakthroughs for the benefit of mankind. 

The IPMP requests proposals for research in the area of precision medicine that will lead to a deeper understanding of human disease and will advance the implementation of new healthcare approaches. Winners will be chosen by an international selection committee according to the criteria outlined below.  
 

Comprised of 14 multidisciplinary teams, the first cohort of the Israel Precision Medicine Partnership (IPMP) received NIS 60 million to advance novel approaches to medical challenges. Nobel laureate and Chair of the international IPMP Selection Committee, Professor Roger Kornberg, discussed the project in a special interview with The Jerusalem Post, in which he emphasized Israel’s enormous relative advantage due to the vast scope and high reliability of its databases.